| 1St6Gal1 | β-galactoside α-2,6-sialyltransferase |
| ACPAs | anti-citrullinated protein antibodies |
| ACTH | adrenocorticotropic hormone |
| AIA | adjuvant induced arthritis |
| bDMARDs | biologic disease-modifying anti-rheumatic drugs |
| BMI | body-mass index |
| CAIA | collagen antibody-induced arthritis |
| CIA | collagen-induced arthritis |
| CRP | C-reactive protein |
| DC | dendritic cells |
| DMARDs | disease-modifying anti-rheumatic drugs |
| ESR | erythrocyte sedimentation rate |
| FLSs | fibroblast-like synoviocytes |
| GDP | gross domestic product |
| HIF-2α | hypoxia-inducible factor-2α |
| HLA | human leukocyte antigen |
| IA | itaconate (methylene succinic acid) |
| IFN-γ | interferon-γ |
| IgG | immunoglobulin G |
| IL | interleukin |
| IRG1 | immune-responsive gene-1 |
| LPS | lipopolysaccharide |
| MC | mast cells |
| MHC | major histocompatibility complex |
| MIA | monoiodoacetate model |
| MMPs | matrix metalloproteinases |
| MT | metallothionein |
| MTF1 | metal-regulatory transcription factor 1; |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NK | natural killer cells |
| NLRP3 | nod-like receptor family pyrin domain containing 3 |
| NO | nitric oxide |
| OA | osteoarthritis |
| PADI4 | peptidylarginine deiminase |
| PHA | phytohaemagglutinin |
| PMNs | blood polymorphonuclear cells |
| PTM | post-translational modification |
| RA | rheumatoid arthritis |
| RF | rheumatoid factor |
| ROS | reactive oxygen species |
| SCFAs | short chain fatty acids |
| SDH | succinate dehydrogenase |
| SOD | superoxide dismutase |
| TCA | Krebs cycle (tricarboxylic acid cycle) |
| Th1 | T helper 1 cells |
| Th17 | T helper 17 cells |
| Th2 | T helper 2 cells |
| TNF-α | tumour necrosis factor-α |
| ZIP | Zrt-/Irt-like protein |
| ZnO NPs | zinc oxide nanoparticles |